• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Search
Skip to main content
Advertisement

"Keytruda"

Search all headlines (in English)
In the last 7 days
Merck and Eisai's Keytruda-Lenvima combo comes up short yet again, this time in endometrial… FiercePharma12:39 8-Dec-23
Merck's (MRK) Keytruda-Lynparza Combo Fails Lung Cancer Study Zacks11:04 8-Dec-23
Novartis preps Kisqali for FDA; Ventyx cuts 20% of workers; Keytruda plus Lenvima hits PhIII setback ENDPOINTS11:01 8-Dec-23
MSD’s Keytruda and Eisai’s Lenvima fail in Phase III uterine cancer trial Pharmaceutical Technology09:34 8-Dec-23
Merck’s Keytruda Flops in Late-Stage Endometrial Carcinoma Study BioSpace09:21 8-Dec-23
Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer Benzinga08:36 8-Dec-23
Merck Says Phase 3 LEAP-001 Trial Evaluating KEYTRUDA Plus LENVIMA Did Not Meet Endpoints RTT News07:51 8-Dec-23
Merck, Eisai: Keytruda/Lenvima Combo Fails in 1st-Line Endometrial Cancer Study MarketWatch07:11 8-Dec-23
Merck halts trial after Keytruda-Lynparza combo flunks PhIII study in lung cancer ENDPOINTS14:21 7-Dec-23
Merck’s Keytruda, Anti-TIGIT Combo Fails Phase II NSCLC Trial BioSpace11:51 7-Dec-23
For Merck, Lynparza fails to improve on Keytruda in first-line lung cancer FiercePharma09:43 7-Dec-23
Merck Scraps Phase 3 Keytruda-Lynparza Lung Cancer Study The Wall Street Journal07:43 7-Dec-23
Merck Announces KEYLYNK-008 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LYNPARZA®… Business Wire (Press Release)06:55 7-Dec-23
In the last month
FDA starts review of Padcev/Keytruda for bladder cancer pharmaphorum06:02 1-Dec-23
FDA accepts Merck’s Keytruda plus Padcev sBLA to treat urothelial cancer Pharmaceutical Technology05:30 1-Dec-23
FDA Grants Priority Review for Supplemental Biologics License Application (sBLA) of PADCEV®… Business Wire (Press Release)17:01 30-Nov-23
KEYTRUDA Drug Insight and Market Insights Report 2023 PR Newswire (Press Release)20:17 27-Nov-23
Coherus prices China-made PD-1 drug Loqtorzi at 20% discount to Merck's Keytruda FiercePharma18:23 27-Nov-23
KEYTRUDA Drug Insight and Market Forecast Report, 2019-2022 & 2023-2032: Focus on 7 Major Markets - United States,… GlobeNewswire (Press Release)10:07 27-Nov-23
Korean biotech firms spearhead biosimilar race for MSD's Keytruda as patent expiry looms Korea Biomedical Review02:24 23-Nov-23
Merck: Keytruda Patent Expiry Nears With Replacement Yet To Be Found Seeking Alpha09:38 22-Nov-23
Merck receives FDA approval for Keytruda combination in gastric cancer PMLiVE07:34 20-Nov-23
Merck notches 38th approval for Keytruda, seventh indication for gastrointestinal cancer ENDPOINTS12:25 17-Nov-23
FDA signs off on new uses for Astellas and Pfizer's Xtandi, Merck's Keytruda FiercePharma11:29 17-Nov-23
Merck (MRK) Gets FDA Nod for Keytruda Expansion in Gastric Cancer Zacks11:08 17-Nov-23
Merck’s Keytruda combo wins FDA approval for gastric cancer Proactive Investors (Canada)10:15 17-Nov-23
Pharma Stock Roundup: FDA Okays AZN's Capivasertib & MRK's Keytruda Expanded Use Zacks07:34 17-Nov-23
Merck Expands Keytruda’s Label as a First-Line Option for Gastric Cancer BioSpace06:55 17-Nov-23
FDA approves Merck’s Keytruda for gastric cancer treatment Pharmafile06:09 17-Nov-23
FDA grants approval for Merck’s Keytruda combo for gastric cancer Pharmaceutical Technology03:42 17-Nov-23
Merck’s Keytruda gets approval to treat certain types of gastric cancer MarketWatch18:01 16-Nov-23
Samsung Bioepis to develop MSD's Keytruda biosimilar The Korea Herald02:43 15-Nov-23
What impact will Keytruda have on treating advanced gastric cancer? Korea Biomedical Review04:27 14-Nov-23
Merck’s Keytruda combination receives CHMP recommendation for biliary tract cancer PMLiVE07:32 13-Nov-23
CHMP provides positive opinion for Merck’s Keytruda Pharmaceutical Technology03:40 13-Nov-23
Merck’s drug Keytruda recommended for EU approval for biliary tract cancer Proactive Investors (Canada)09:12 10-Nov-23
Merck Gets CHMP Backing for Keytruda in Biliary Tract Cancer MarketWatch08:09 10-Nov-23
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Gemcitabine and… Business Wire (Press Release)07:42 10-Nov-23
view more headlines
8 Dec 12:39
Publication filters

Headline Density

Notifications

  • Unsubscribe from Breaking News
    Sorry, no headlines or news topics were found. Please try different keywords.